CELU Stock Summary and Trading Ideas (Celularity - Class A | NASDAQ:CELU)

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Celularity - Class A trades on the NASDAQ stock market under the symbol CELU.

As of December 19, 2025, CELU stock price climbed to $1.45 with 115,272 million shares trading.

CELU has a beta of 1.90, meaning it tends to be more sensitive to market movements. CELU has a correlation of 0.10 to the broad based SPY ETF.

CELU has a market cap of $41.08 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, CELU traded as high as $14.75 and as low as $1.00.

The top ETF exchange traded funds that CELU belongs to (by Net Assets): VTI, VXF, IWC.

CELU has underperformed the market in the last year with a price return of -35.3% while the SPY ETF gained +17.3%. CELU has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -33.8% and -26.5%, respectively, while the SPY returned +3.3% and -0.6%, respectively.

CELU support price is $1.17 and resistance is $1.34 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CELU shares will trade within this expected range on the day.